Skip Nav Destination
Close Modal
Update search
- Title
- Author
- Full Text
- Abstract
- Keyword
- DOI
- Title
- Author
- Full Text
- Abstract
- Keyword
- DOI
- Title
- Author
- Full Text
- Abstract
- Keyword
- DOI
- Title
- Author
- Full Text
- Abstract
- Keyword
- DOI
- Title
- Author
- Full Text
- Abstract
- Keyword
- DOI
- Title
- Author
- Full Text
- Abstract
- Keyword
- DOI
NARROW
Publications
Format
Subjects
Article Type
Topics
Date
Availability
1-20 of 5685
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
From treatment to biology and back: managing iron overload in transfused hemoglobinopathies
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 103–110.
Published: 2025
Journal Articles
Buckle up! Managing surgery in patients with bleeding disorder of unknown cause
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 111–115.
Published: 2025
Journal Articles
Diagnosis of bleeding disorder of unknown cause: how many tests are enough to diagnose BDUC?
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 116–119.
Published: 2025
Journal Articles
Predictors for future bleeding in bleeding disorder of unknown cause
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 120–126.
Published: 2025
Journal Articles
(Un) Diagnosing von Willebrand disease
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 127–130.
Published: 2025
Journal Articles
What's new in hereditary hemorrhagic telangiectasia?
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 131–136.
Published: 2025
Journal Articles
When it's not Glanzmann thrombasthenia or Bernard-Soulier syndrome: diagnosing other qualitative platelet disorders
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 137–146.
Published: 2025
Journal Articles
Long-term outcome and management of complement-mediated thrombotic microangiopathy/aHUS
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 147–153.
Published: 2025
Journal Articles
The varieties of therapeutic experience: navigating treatment options for patients with PNH
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 154–163.
Published: 2025
Journal Articles
Cryptogenic stroke: definitions and management
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 15–21.
Published: 2025
Journal Articles
Update in the diagnosis of complement-mediated thrombotic microangiopathy/atypical hemolytic uremic syndrome
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 164–175.
Published: 2025
Journal Articles
Anticoagulation in malignancy: the patient who bleeds and clots simultaneously
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 176–182.
Published: 2025
Journal Articles
JAK2 wild-type erythrocytosis: concept, differential diagnosis, diagnostic steps, and treatment approaches
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 183–190.
Published: 2025
Journal Articles
The untransfusable patient
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 191–198.
Published: 2025
Journal Articles
The xanthogranuloma family of histiocytic neoplasms in the molecular era: Erdheim-Chester disease and beyond
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 199–205.
Published: 2025
Journal Articles
Hemophagocytic lymphohistiocytosis: do we have a solution for TMI (too much inflammation)?
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 206–214.
Published: 2025
Journal Articles
Advances in the diagnosis and management of pediatric Langerhans cell histiocytosis and Rosai-Dorfman disease: therapies, biomarkers, and response assessment
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 215–228.
Published: 2025
Journal Articles
The challenge of deintensifying chemotherapy for children and adolescents with B-ALL in the immunotherapy era
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 229–235.
Published: 2025
Journal Articles
Managing patients with a history of arterial disease and new venous thromboembolism
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 22–33.
Published: 2025
Journal Articles
Immune targeting in Ph-negative and Ph-positive B-ALL: improving outcomes and minimizing chemotherapy in adult B-ALL
Available to Purchase
Journal:
Hematology
Hematology Am Soc Hematol Educ Program (2025) 2025 (1): 236–244.
Published: 2025
1
